Total survival | Disease-specific survival | |||||
---|---|---|---|---|---|---|
HR | 95% CI (HR) | P value | HR | 95% CI (HR) | P value | |
Gender | 0.52 | 0.18–1.52 | 0.236 | 0.35 | 0.10–1.31 | 0.119 |
Age | 1.07 | 1.02–1.11 | 0.002 | 1.08 | 1.03–1.28 | 0.002 |
IL-6 | 2.27 | 1.05–4.88 | 0.036 | 2.68 | 1.11–6.45 | 0.028 |
Gender | 0.54 | 0.20–1.50 | 0.237 | 0.40 | 0.11–1.41 | 0.153 |
Age | 1.06 | 1.02–1.11 | 0.008 | 1.06 | 1.01–1.11 | 0.025 |
T stage | 1.64 | 1.18–2.29 | 0.003 | 1.89 | 1.29–2.79 | 0.001 |
N stage | 1.55 | 1.06–2.28 | 0.025 | 1.61 | 1.03–2.51 | 0.035 |
IL-6 | 2.08 | 0.97–4.48 | 0.061 | 2.44 | 1.01–5.92 | 0.049 |